JD Health prices HK$27bn IPO high on strong investor support

JD Health International has raised HK$27bn ($3.5bn) after sealing its IPO at the top end of the marketed range, following a flood of global investor demand.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: